Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Andrew SaikCFO | ArvinasARVN | Open-market sale10b5-1 plan | 06/24 | 06/24 | 5,696 sh | $8.16 | $46,479.36 | −2.9% |
Angela M. CacaceChief Scientific Officer | ArvinasARVN | Open-market sale10b5-1 plan | 06/17 | 06/18 | 2,576 sh | $7.60 | $19,577.6 | −1.4% |
Randy TeelPresident and CEO | ArvinasARVN | Open-market sale | 05/21 | 05/22 | 2,209 sh | $9.04 | $19,969.36 | −0.8% |
Noah BerkowitzChief Medical Officer | ArvinasARVN | Open-market sale | 05/11 | 05/13 | 11,108 sh | $9.94 | $110,413.52 | −5.5% |
Andrew SaikCFO | ArvinasARVN | Open-market sale | 05/11 | 05/13 | 11,139 sh | $9.94 | $110,721.66 | −5.5% |
David K. LoomisVP, Chief Accounting Officer | ArvinasARVN | Open-market sale | 05/11 | 05/13 | 1,919 sh | $9.94 | $19,074.86 | −4.6% |
Randy TeelPresident and CEO | ArvinasARVN | Open-market sale | 05/11 | 05/13 | 9,657 sh | $9.94 | $95,990.58 | −3.3% |
Angela M. CacaceChief Scientific Officer | ArvinasARVN | Open-market sale | 05/11 | 05/13 | 9,657 sh | $9.94 | $95,990.58 | −5.0% |
Noah BerkowitzChief Medical Officer | ArvinasARVN | Open-market sale | 03/18 | 03/19 | 6,435 sh | $11.10 | $71,428.5 | −3.1% |
Briggs MorrisonDirector | ArvinasARVN | Open-market buy | 03/06 | 03/09 | 20,000 sh | $13.40 | $268,000 | +26.3% |
ArvinasARVN | Open-market sale | 02/27 | 03/02 | 35,297 sh3 trades | $13.21avg. | $466,153.58 | −3.0% | |
David K. LoomisChief Accounting Officer | ArvinasARVN | Open-market sale | 02/23 | 02/25 | 1,108 sh | $12.16 | $13,473.28 | −3.6% |
ArvinasARVN | Open-market sale | 02/23 | 02/25 | 4,786 sh2 trades | $12.16avg. | $58,197.76 | −3.1% | |
ArvinasARVN | Open-market sale | 02/23 | 02/25 | 3,609 sh2 trades | $12.16avg. | $43,885.44 | −2.4% | |
Noah BerkowitzChief Medical Officer | ArvinasARVN | Open-market sale | 02/13 | 02/18 | 5,685 sh | $11.89 | $67,594.65 | −3.4% |
Andrew SaikCFO | ArvinasARVN | Open-market sale | 02/13 | 02/18 | 5,134 sh | $11.89 | $61,043.26 | −3.1% |
David K. LoomisChief Accounting Officer | ArvinasARVN | Open-market sale | 02/13 | 02/18 | 1,016 sh | $11.89 | $12,080.24 | −3.2% |
Randy TeelPresident and CEO | ArvinasARVN | Open-market sale | 02/13 | 02/18 | 4,403 sh | $11.89 | $52,351.67 | −2.8% |
Angela M. CacaceChief Scientific Officer | ArvinasARVN | Open-market sale | 02/13 | 02/18 | 4,592 sh | $11.89 | $54,598.88 | −2.9% |
David K. LoomisChief Accounting Officer | ArvinasARVN | Open-market sale | 25/11/07 | 25/11/07 | 230 sh | $9.89 | $2,274.7 | −0.7% |